Osteoporosis is one of those Step 1 topics that’s deceptively simple: “old woman, hip fracture.” But the exam writers love testing the why—hormones, cytokines, bone remodeling, medication adverse effects, and which labs are normal vs abnormal. If you can anchor osteoporosis to calcium & bone metabolism, you’ll pick up easy points across Endocrine, MSK, and Pharm.
Big-Picture Definition (What Osteoporosis Is and Isn’t)
Osteoporosis = decreased bone mass with normal mineralization → increased fracture risk.
- Think: “The building is smaller, but the bricks are normal.”
- Compare with:
- Osteomalacia/rickets = defective mineralization (low Ca/PO₄/Vit D problems).
- Paget disease = disorganized remodeling (mixed lytic/blastic).
- Osteopetrosis = increased bone density but brittle (osteoclast failure).
Key Step 1 phrase: “Normal labs” in primary osteoporosis (Ca, PO₄, PTH, ALP typically normal).
Bone Remodeling Refresher (High-Yield Physiology)
Bone is constantly remodeled by:
- Osteoclasts (resorb bone) — derived from monocyte/macrophage lineage
- Osteoblasts (build bone) — derived from mesenchymal cells
RANK/RANKL/OPG (Tested All the Time)
- RANK: on osteoclast precursors
- RANKL: produced by osteoblasts/stromal cells → binds RANK → osteoclast activation
- OPG (osteoprotegerin): “decoy receptor” made by osteoblasts → binds RANKL → decreases osteoclast activation
Estrogen increases OPG → decreases osteoclast activity.
So when estrogen drops (e.g., menopause), OPG drops → osteoclast activity rises → bone loss accelerates.
Pathophysiology: Why Bone Gets Fragile
Primary Osteoporosis
-
Postmenopausal osteoporosis
- ↓ Estrogen → ↑ osteoclast activity via ↓ OPG and ↑ cytokines (e.g., IL-1, IL-6, TNF)
- Rapid bone loss early after menopause
- Vertebral compression fractures are classic
-
Senile osteoporosis
- Age-related: decreased osteoblast activity, decreased calcium absorption, reduced physical activity
- Tends to affect cortical and trabecular bone over time
- Hip fractures become more common
Secondary Osteoporosis (High-Yield Causes)
Think “bones hate steroids and endocrine disease.”
Common Step associations:
- Glucocorticoids (very HY)
- Hyperparathyroidism (PTH-mediated bone resorption)
- Hyperthyroidism
- Hypogonadism (low estrogen/testosterone)
- Alcohol use disorder
- Smoking
- Malabsorption (celiac, bariatric surgery)
- Chronic kidney disease → can overlap with renal osteodystrophy (different lab pattern)
Clinical Presentation (What the Stem Looks Like)
Many patients are asymptomatic until fracture.
Classic Fractures
- Vertebral compression fractures
- Sudden back pain after minor strain
- Loss of height
- Kyphosis (“dowager hump”)
- Hip fracture (femoral neck/intertrochanteric) after fall from standing
- Distal radius fracture (Colles) after FOOSH
Exam Tip: Osteoporosis vs Osteomalacia
- Osteoporosis: fractures + height loss with normal labs
- Osteomalacia: bone pain, proximal muscle weakness with abnormal labs (often ↓ Vit D, ↓ Ca/PO₄, ↑ PTH, ↑ ALP)
Diagnosis (Step 1 Essentials)
DEXA Scan (Dual-energy X-ray absorptiometry)
Reported as T-score (compared to young healthy adult mean).
| T-score | Interpretation |
|---|---|
| Normal | |
| to | Osteopenia |
| Osteoporosis | |
| + fragility fracture | Severe/established osteoporosis |
Fragility fracture = fracture from low-energy mechanism (e.g., fall from standing).
Labs
- Primary osteoporosis: typically normal Ca, PO₄, PTH, ALP
- Labs are mainly used to evaluate secondary causes when the story doesn’t fit (young patient, atypical fractures, abnormal exam, medication history).
Imaging Clues
- X-ray may show vertebral compression and reduced bone density, but DEXA is diagnostic.
Treatment (Mechanisms + High-Yield Toxicities)
Lifestyle + Prevention (Always Fair Game)
- Weight-bearing exercise
- Adequate calcium and vitamin D intake
- Fall prevention (vision correction, home safety)
- Stop smoking, reduce alcohol
Pharmacologic Therapy (Core Step 1 Drugs)
Bisphosphonates (First-line)
Examples: alendronate, risedronate, ibandronate, zoledronate
Mechanism: bind hydroxyapatite; inhibit osteoclasts → decrease bone resorption
(First Aid classic: “incorporate into bone, inhibit osteoclast-mediated bone resorption”)
Administration pearl: oral forms must be taken with water; remain upright for 30+ minutes.
Adverse effects (HY):
- Esophagitis
- Osteonecrosis of the jaw
- Atypical femoral fractures (with long-term use)
Denosumab
Mechanism: monoclonal antibody against RANKL → prevents osteoclast activation.
Adverse effects: hypocalcemia (especially if low vitamin D), infections/dermatologic reactions (less Step-heavy but worth recognizing).
Teriparatide (PTH analog)
Mechanism: intermittent PTH → stimulates osteoblasts > osteoclasts → increases bone formation
Big warning: contraindicated in patients at risk for osteosarcoma (e.g., Paget disease, prior radiation) — very board-style.
SERMs (Raloxifene)
Mechanism: estrogen agonist in bone → decreases resorption
Adverse effects (HY):
- Increased risk of thromboembolism
- Hot flashes
- (Bonus association) reduces breast cancer risk due to antagonist effect in breast
Calcitonin
Less potent; sometimes used for pain relief in vertebral compression fractures. Mechanism: directly inhibits osteoclasts.
Estrogen therapy
Can prevent bone loss but not commonly first-line due to risks (VTE, breast cancer, etc.). Step 1 may test it conceptually: estrogen protects bone.
High-Yield “Classic Stem” Associations
1) Postmenopausal woman + vertebral compression fractures
- Normal Ca/PO₄/PTH
- DEXA T-score
2) Chronic steroid use
- Secondary osteoporosis is a major complication
- Think asthma/COPD, autoimmune disease, transplant patient
3) Hyperparathyroidism vs osteoporosis
- Primary hyperparathyroidism: “stones, bones…” with ↑ Ca, ↓ PO₄, ↑ PTH, subperiosteal resorption
- Osteoporosis alone: labs normal
4) Bisphosphonate toxicity
- Jaw osteonecrosis after dental procedure
- Esophageal irritation symptoms
5) Osteoporosis vs osteomalacia quick discriminator
- Osteomalacia: bone pain + weakness + abnormal labs
- Osteoporosis: fractures + normal labs
Rapid-Fire Step 1 Checklist (If You Remember Nothing Else)
- Osteoporosis = ↓ bone mass, normal mineralization
- T-score = osteoporosis
- Most primary osteoporosis labs are normal
- Estrogen normally inhibits osteoclasts via ↑ OPG and ↓ cytokines
- First-line drugs: bisphosphonates
- AEs: esophagitis, ONJ, atypical femur fractures
- Denosumab blocks RANKL
- Teriparatide (intermittent PTH) builds bone
First Aid Cross-References (Where This Lives Conceptually)
Use these as “mental bookmarks” while flipping through First Aid:
- Endocrine: Calcium, phosphate, PTH, vitamin D regulation
- MSK: Bone disorders
- Pharm: Drugs affecting bone mineral density
- Bisphosphonates
- Denosumab
- Teriparatide
- Raloxifene
- Calcitonin
- Repro/Endocrine overlap: menopause → estrogen loss → bone loss
(Edition/page numbers vary, but these headings are consistent across versions.)